Company / Debt per Share
GeneDx Holdings Corp. Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.95
FY2025
5-year range
$1.95 / $88709.68
FY2021-FY2025
Trend
-9.3%
vs FY2024
Sector context
#84 of 100
Health Care
What the data says
GeneDx Holdings Corp.'s debt per share of $1.95 is lower than 84% of companies in the Health Care sector (FY2025). Debt per Share has declined for 4 consecutive years, from $88709.68 in FY2021 to $1.95 in FY2025.
Based on SEC 10-K filings.
1.95 in FY2025 with a 5-year CAGR of -77.9%.
Improved from $4.78 to $1.95 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -90.3%
- 5-Year CAGR
- -77.9%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 100This company $1.95 Sector average $45.62
▼
-95.7% below sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s debt per share has declined for 4 consecutive years.
- In FY2025, debt per share decreased 9.3% year-over-year.
- Ranks #84 out of 100 companies in the Health Care sector.
- Peak debt per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.95 | -9.3% |
| FY2024 | $2.15 | -55.1% |
| FY2023 | $4.78 | -99.8% |
| FY2022 | $2143.83 | -97.6% |
| FY2021 | $88709.68 | +2299.3% |
| FY2020 | $3697.33 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026